CymaBay Therapeutics, Inc. - 23257D103
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2024
· Q4 2023
Value (USD)
Total reported value ($000)
$18.61M
QoQ value delta ($000)
-$1.935B
(-99.05%)
Implied price effect (QoQ)
+0.03%
Shares
Total shares
787,547
QoQ shares delta
-81,926,774
(-99.05%)
Total shares held by funds (by quarter)
Top holders (Q1 2024)
Top 25 only
Full list
Partial Q1 2024 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 18,586 | 786,897 | 0.02% |
| IFP Advisors, Inc | 21 | 650 | 0.0% |